INS and breast cancer: Conversely, caloric restriction or intermittent fasting, a period of voluntary abstention from all food or specific food products [122], can negatively impact BC development, reduce the treatment-induced adverse effects, cytotoxicity, and DNA damage, and increase optimal glycemic regulation, improving serum glucose, insulin, and insulin-like growth factor 1 (IGF-1) levels [123].